Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

12-Month stability of neurological soft signs in stabilized patients with schizophrenia.

Fountoulakis KN, Panagiotidis P, Kimiskidis V, Nimatoudis I.

Nord J Psychiatry. 2019 Oct;73(7):451-461. doi: 10.1080/08039488.2019.1649724. Epub 2019 Aug 8.

PMID:
31393751
2.

Autologous Hematopoietic Cell Transplantation in Multiple Sclerosis: Changing Paradigms in the Era of Novel Agents.

Gavriilaki M, Sakellari I, Gavriilaki E, Kimiskidis VK, Anagnostopoulos A.

Stem Cells Int. 2019 Jun 24;2019:5840286. doi: 10.1155/2019/5840286. eCollection 2019. Review.

3.

Working memory profiles of patients with multiple sclerosis: Where does the impairment lie?

Kouvatsou Z, Masoura E, Kiosseoglou G, Kimiskidis VK.

J Clin Exp Neuropsychol. 2019 Oct;41(8):832-844. doi: 10.1080/13803395.2019.1626805. Epub 2019 Jun 17.

PMID:
31204607
4.

Neurological adverse events post allogeneic hematopoietic cell transplantation: major determinants of morbidity and mortality.

Sakellari I, Gavriilaki E, Papagiannopoulos S, Gavriilaki M, Batsis I, Mallouri D, Vardi A, Constantinou V, Masmanidou M, Yannaki E, Smias C, Geroukis T, Kazis D, Kimiskidis V, Anagnostopoulos A.

J Neurol. 2019 Aug;266(8):1960-1972. doi: 10.1007/s00415-019-09372-3. Epub 2019 May 13.

PMID:
31087160
5.

Introduction.

Kimiskidis VK, Schachter S.

Int J Neural Syst. 2019 May;29(4):1902001. doi: 10.1142/S0129065719020015. Epub 2019 Apr 11. No abstract available.

PMID:
30975004
6.

Diagnostic accuracy of interictal source imaging in presurgical epilepsy evaluation: A systematic review from the E-PILEPSY consortium.

Mouthaan BE, Rados M, Boon P, Carrette E, Diehl B, Jung J, Kimiskidis V, Kobulashvili T, Kuchukhidze G, Larsson PG, Leitinger M, Ryvlin P, Rugg-Gunn F, Seeck M, Vulliémoz S, Huiskamp G, Leijten FSS, Van Eijsden P, Trinka E, Braun KPJ; E-PILEPSY consortium.

Clin Neurophysiol. 2019 May;130(5):845-855. doi: 10.1016/j.clinph.2018.12.016. Epub 2019 Feb 8.

PMID:
30824202
7.

Clinical utility and prospective of TMS-EEG.

Tremblay S, Rogasch NC, Premoli I, Blumberger DM, Casarotto S, Chen R, Di Lazzaro V, Farzan F, Ferrarelli F, Fitzgerald PB, Hui J, Ilmoniemi RJ, Kimiskidis VK, Kugiumtzis D, Lioumis P, Pascual-Leone A, Pellicciari MC, Rajji T, Thut G, Zomorrodi R, Ziemann U, Daskalakis ZJ.

Clin Neurophysiol. 2019 May;130(5):802-844. doi: 10.1016/j.clinph.2019.01.001. Epub 2019 Jan 19. Review.

PMID:
30772238
8.

Reproducibility in TMS-EEG studies: A call for data sharing, standard procedures and effective experimental control.

Belardinelli P, Biabani M, Blumberger DM, Bortoletto M, Casarotto S, David O, Desideri D, Etkin A, Ferrarelli F, Fitzgerald PB, Fornito A, Gordon PC, Gosseries O, Harquel S, Julkunen P, Keller CJ, Kimiskidis VK, Lioumis P, Miniussi C, Rosanova M, Rossi S, Sarasso S, Wu W, Zrenner C, Daskalakis ZJ, Rogasch NC, Massimini M, Ziemann U, Ilmoniemi RJ.

Brain Stimul. 2019 May - Jun;12(3):787-790. doi: 10.1016/j.brs.2019.01.010. Epub 2019 Jan 19. No abstract available.

9.

Lacosamide as a first-line treatment option in focal epilepsy: a cost-utility analysis for the Greek healthcare system.

Geitona M, Stamuli E, Giannakodimos S, Kimiskidis VK, Kountouris V, Charokopou M, Christou P.

J Med Econ. 2019 Apr;22(4):359-364. doi: 10.1080/13696998.2019.1571499. Epub 2019 Feb 8.

PMID:
30652931
10.

Corrigendum to "Neurological soft signs significantly differentiate schizophrenia patients from healthy controls"; [Acta Neuropsychiatrica 2018;30(2):97-105].

Fountoulakis KN, Panagiotidis P, Gonda X, Kimiskidis V, Nimatoudis I.

Acta Neuropsychiatr. 2019 Feb;31(1):61. doi: 10.1017/neu.2018.37. Epub 2019 Jan 9. No abstract available.

PMID:
30621804
11.

Neurological soft signs in familial and sporadic schizophrenia.

Fountoulakis KN, Panagiotidis P, Kimiskidis V, Nimatoudis I, Gonda X.

Psychiatry Res. 2019 Feb;272:222-229. doi: 10.1016/j.psychres.2018.12.105. Epub 2018 Dec 20.

PMID:
30590276
12.

Identification of Hidden Sources by Estimating Instantaneous Causality in High-Dimensional Biomedical Time Series.

Koutlis C, Kimiskidis VK, Kugiumtzis D.

Int J Neural Syst. 2019 May;29(4):1850051. doi: 10.1142/S012906571850051X. Epub 2018 Oct 29.

PMID:
30563386
13.

Reader response: Usefulness of ADAMTS13 to predict response to recanalization therapies in acute ischemic stroke.

Gavriilaki M, Sakellari I, Kimiskidis V.

Neurology. 2018 Nov 6;91(19):898-899. doi: 10.1212/WNL.0000000000006464. No abstract available.

PMID:
30397045
14.

Lithium monotherapy-induced tardive dyskinesia.

Fountoulakis KN, Tegos T, Kimiskidis V.

J Affect Disord. 2019 Feb 1;244:78-79. doi: 10.1016/j.jad.2018.10.094. Epub 2018 Oct 9.

PMID:
30321768
15.

Theory of Mind impairment in focal versus generalized epilepsy.

Morou N, Papaliagkas V, Markouli E, Karagianni M, Nazlidou E, Spilioti M, Afrantou T, Kimiskidis VK, Foroglou N, Kosmidis MH.

Epilepsy Behav. 2018 Nov;88:244-250. doi: 10.1016/j.yebeh.2018.09.026. Epub 2018 Oct 11.

PMID:
30317058
16.

Functional rhythmic tongue movements.

Giza E, Dagklis IE, Kimiskidis V, Katsarou Z, Bostantjopoulou S.

Acta Neurol Belg. 2018 Jul 10. doi: 10.1007/s13760-018-0983-z. [Epub ahead of print] No abstract available.

PMID:
29987754
17.

The cortical excitability profile of patients with the G209A SNCA mutation versus patients with sporadic Parkinson's disease: A transcranial magnetic stimulation study.

Kimiskidis VK, Papayiannopoulos S, Sotirakoglou K, Karakasis H, Katsarou Z, Kazis DA, Papaliagkas V, Gatzonis S, Papadimitriou A, Hadjigeorgiou G, Bostanjopoulou S.

Neurophysiol Clin. 2018 Sep;48(4):203-206. doi: 10.1016/j.neucli.2018.04.002. Epub 2018 May 3.

PMID:
29729894
18.

Prevalence and correlates of neurological soft signs in healthy controls without family history of any mental disorder: A neurodevelopmental variation rather than a specific risk factor?

Fountoulakis KN, Panagiotidis P, Kimiskidis V, Nimatoudis I, Gonda X.

Int J Dev Neurosci. 2018 Aug;68:59-65. doi: 10.1016/j.ijdevneu.2018.04.006. Epub 2018 Apr 27.

PMID:
29705589
19.

Neurological soft signs significantly differentiate schizophrenia patients from healthy controls.

Fountoulakis KN, Panagiotidis P, Gonda X, Kimiskidis V, Nimatoudis I.

Acta Neuropsychiatr. 2018 Apr;30(2):97-105. doi: 10.1017/neu.2017.29. Epub 2017 Nov 29. Erratum in: Acta Neuropsychiatr. 2019 Feb;31(1):61.

PMID:
29183417
20.

Central motor pathways in tropical spastic paraparesis: a combined transcranial magnetic stimulation and diffusion tensor imaging study.

Kimiskidis VK, Papaliagkas V, Kazis DA, Geroukis T, Bostantjopoulou S.

Hippokratia. 2017 Oct-Dec;21(4):191-193.

21.

Introduction.

Kimiskidis VK, Ryvlin P, Schachter S.

Int J Neural Syst. 2017 Nov;27(7):1702002. doi: 10.1142/S0129065717020026. Epub 2017 Aug 18. No abstract available.

PMID:
28820001
22.

Dynamics of Epileptiform Discharges Induced by Transcranial Magnetic Stimulation in Genetic Generalized Epilepsy.

Kugiumtzis D, Koutlis C, Tsimpiris A, Kimiskidis VK.

Int J Neural Syst. 2017 Nov;27(7):1750037. doi: 10.1142/S012906571750037X. Epub 2017 Jul 18.

PMID:
28774230
23.

Dimension reduction of frequency-based direct Granger causality measures on short time series.

Siggiridou E, Kimiskidis VK, Kugiumtzis D.

J Neurosci Methods. 2017 Sep 1;289:64-74. doi: 10.1016/j.jneumeth.2017.06.021. Epub 2017 Jul 4.

PMID:
28687522
24.

Source localization of ictal epileptic activity based on high-density scalp EEG data.

Nemtsas P, Birot G, Pittau F, Michel CM, Schaller K, Vulliemoz S, Kimiskidis VK, Seeck M.

Epilepsia. 2017 Jun;58(6):1027-1036. doi: 10.1111/epi.13749. Epub 2017 Apr 11.

25.

The Hemiconvulsions-Hemiplegia-Epilepsy (HHE) syndrome: a transcranial magnetic stimulation-EEG study.

Kimiskidis VK, Sotirakoglou K, Kazis DA, Papaliagkas V, Chatzikyriakou E.

Hippokratia. 2017 Apr-Jun;21(2):101.

26.

Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis.

Muraro PA, Pasquini M, Atkins HL, Bowen JD, Farge D, Fassas A, Freedman MS, Georges GE, Gualandi F, Hamerschlak N, Havrdova E, Kimiskidis VK, Kozak T, Mancardi GL, Massacesi L, Moraes DA, Nash RA, Pavletic S, Ouyang J, Rovira M, Saiz A, Simoes B, Trnený M, Zhu L, Badoglio M, Zhong X, Sormani MP, Saccardi R; Multiple Sclerosis–Autologous Hematopoietic Stem Cell Transplantation (MS-AHSCT) Long-term Outcomes Study Group.

JAMA Neurol. 2017 Apr 1;74(4):459-469. doi: 10.1001/jamaneurol.2016.5867.

27.

Investigation of the motor system in two siblings with Canavan's disease: a combined transcranial magnetic stimulation (TMS) - diffusion tensor imaging (DTI) study.

Kimiskidis VK, Papaliagkas V, Papagiannopoulos S, Zafeiriou D, Kazis D, Tsatsali-Foroglou E, Kouvatsou Z, Kapina V, Koutsonikolas D, Anogianakis G, Geroukis T, Bostantjopoulou S.

Metab Brain Dis. 2017 Apr;32(2):307-310. doi: 10.1007/s11011-017-9955-x. Epub 2017 Jan 28.

PMID:
28130616
28.

Current standards of neuropsychological assessment in epilepsy surgery centers across Europe.

Vogt VL, Äikiä M, Del Barrio A, Boon P, Borbély C, Bran E, Braun K, Carette E, Clark M, Cross JH, Dimova P, Fabo D, Foroglou N, Francione S, Gersamia A, Gil-Nagel A, Guekht A, Harrison S, Hecimovic H, Heminghyt E, Hirsch E, Javurkova A, Kälviäinen R, Kavan N, Kelemen A, Kimiskidis VK, Kirschner M, Kleitz C, Kobulashvili T, Kosmidis MH, Kurtish SY, Lesourd M, Ljunggren S, Lossius MI, Malmgren K, Mameniskiené R, Martin-Sanfilippo P, Marusic P, Miatton M, Özkara Ç, Pelle F, Rubboli G, Rudebeck S, Ryvlin P, van Schooneveld M, Schmid E, Schmidt PM, Seeck M, Steinhoff BJ, Shavel-Jessop S, Tarta-Arsene O, Trinka E, Viggedal G, Wendling AS, Witt JA, Helmstaedter C; E-PILEPSY consortium.

Epilepsia. 2017 Mar;58(3):343-355. doi: 10.1111/epi.13646. Epub 2017 Jan 9.

29.

Dysfibrinogenemia and multiple sclerosis: spuriously associated or causally linked?

Kimiskidis VK, Papadakis E, Papaliagkas V, Papagiannopoulos S, Galanakis DK.

Hippokratia. 2017 Jan-Mar;21(1):49-51.

30.

TMS combined with EEG in genetic generalized epilepsy: A phase II diagnostic accuracy study.

Kimiskidis VK, Tsimpiris A, Ryvlin P, Kalviainen R, Koutroumanidis M, Valentin A, Laskaris N, Kugiumtzis D.

Clin Neurophysiol. 2017 Feb;128(2):367-381. doi: 10.1016/j.clinph.2016.11.013. Epub 2016 Nov 24.

PMID:
28007469
31.

Cognitive event-related potentials in multiple sclerosis: Correlation with MRI and neuropsychological findings.

Kimiskidis VK, Papaliagkas V, Sotirakoglou K, Kouvatsou ZK, Kapina VK, Papadaki E, Tsimourtou V, Masoura E, Kazis DA, Papayiannopoulos S, Geroukis T, Bostanjopoulou S.

Mult Scler Relat Disord. 2016 Nov;10:192-197. doi: 10.1016/j.msard.2016.10.006. Epub 2016 Oct 27.

PMID:
27919489
32.

Central nervous system involvement in multiple symmetric lipomatosis.

Kimiskidis VK, Papaliagkas V, Papagiannopoulos S, Giovos I, Lazaridis L, Kazis DA, Polychronakos C, Geroukis T, Bostantjopoulou S.

J Neurol Sci. 2016 Nov 15;370:27-28. doi: 10.1016/j.jns.2016.09.004. Epub 2016 Sep 8. No abstract available.

PMID:
27772774
33.

The impact of paclitaxel and carboplatin chemotherapy on the autonomous nervous system of patients with ovarian cancer.

Dermitzakis EV, Kimiskidis VK, Lazaridis G, Alexopoulou Z, Timotheadou E, Papanikolaou A, Romanidou O, Georgiadis G, Kalogeras KT, Tsiptsios I, Tarlatzis B, Fountzilas G.

BMC Neurol. 2016 Oct 1;16(1):190.

34.

Treatment of a female patient with persistent genital arousal and Parkinson's disease with paliperidone.

Fountoulakis KN, Tegos T, Goulis DG, Nimatoudis I, Kimiskidis V.

Aust N Z J Psychiatry. 2017 Jan;51(1):98-99. doi: 10.1177/0004867416660200. Epub 2016 Jul 20. No abstract available.

PMID:
27422565
35.

Cortico-cortical and motor evoked potentials to single and paired-pulse stimuli: An exploratory transcranial magnetic and intracranial electric brain stimulation study.

Boulogne S, Andre-Obadia N, Kimiskidis VK, Ryvlin P, Rheims S.

Hum Brain Mapp. 2016 Nov;37(11):3767-3778. doi: 10.1002/hbm.23274.

PMID:
27312488
36.

Current practices in long-term video-EEG monitoring services: A survey among partners of the E-PILEPSY pilot network of reference for refractory epilepsy and epilepsy surgery.

Kobulashvili T, Höfler J, Dobesberger J, Ernst F, Ryvlin P, Cross JH, Braun K, Dimova P, Francione S, Hecimovic H, Helmstaedter C, Kimiskidis VK, Lossius MI, Malmgren K, Marusic P, Steinhoff BJ, Boon P, Craiu D, Delanty N, Fabo D, Gil-Nagel A, Guekht A, Hirsch E, Kalviainen R, Mameniskiené R, Özkara Ç, Seeck M, Rubboli G, Krsek P, Rheims S, Trinka E.

Seizure. 2016 May;38:38-45. doi: 10.1016/j.seizure.2016.03.009. Epub 2016 Apr 1.

37.

Current use of imaging and electromagnetic source localization procedures in epilepsy surgery centers across Europe.

Mouthaan BE, Rados M, Barsi P, Boon P, Carmichael DW, Carrette E, Craiu D, Cross JH, Diehl B, Dimova P, Fabo D, Francione S, Gaskin V, Gil-Nagel A, Grigoreva E, Guekht A, Hirsch E, Hecimovic H, Helmstaedter C, Jung J, Kalviainen R, Kelemen A, Kimiskidis V, Kobulashvili T, Krsek P, Kuchukhidze G, Larsson PG, Leitinger M, Lossius MI, Luzin R, Malmgren K, Mameniskiene R, Marusic P, Metin B, Özkara C, Pecina H, Quesada CM, Rugg-Gunn F, Rydenhag B, Ryvlin P, Scholly J, Seeck M, Staack AM, Steinhoff BJ, Stepanov V, Tarta-Arsene O, Trinka E, Uzan M, Vogt VL, Vos SB, Vulliémoz S, Huiskamp G, Leijten FS, Van Eijsden P, Braun KP; E-PILEPSY consortium.

Epilepsia. 2016 May;57(5):770-6. doi: 10.1111/epi.13347. Epub 2016 Mar 25.

38.

Transcranial magnetic stimulation (TMS) coupled with electroencephalography (EEG): Biomarker of the future.

Kimiskidis VK.

Rev Neurol (Paris). 2016 Feb;172(2):123-6. doi: 10.1016/j.neurol.2015.11.004. Epub 2016 Feb 5. Review.

PMID:
26857413
39.

Causality networks from multivariate time series and application to epilepsy.

Siggiridou E, Koutlis C, Tsimpiris A, Kimiskidis VK, Kugiumtzis D.

Conf Proc IEEE Eng Med Biol Soc. 2015 Aug;2015:4041-4. doi: 10.1109/EMBC.2015.7319281.

PMID:
26737181
40.

Differential effects of lacosamide, phenytoin and topiramate on peripheral nerve excitability: An ex vivo electrophysiological study.

Zafeiridou G, Spilioti M, Kagiava A, Krikonis K, Kosmidis EK, Karlovasitou A, Kimiskidis VK.

Neurotoxicology. 2016 Jan;52:57-63. doi: 10.1016/j.neuro.2015.10.016. Epub 2015 Nov 2.

PMID:
26542247
41.

Computational and Technological Innovations for Epilepsy Diagnosis and Control. Introduction.

Kimiskidis VK, Lesser RP, Schachter S.

Int J Neural Syst. 2015 Aug;25(5):1503001. doi: 10.1142/S012906571503001X. Epub 2015 Jun 9. No abstract available.

PMID:
26058400
42.

Transcranial Magnetic Stimulation Combined with EEG Reveals Covert States of Elevated Excitability in the Human Epileptic Brain.

Kimiskidis VK, Koutlis C, Tsimpiris A, Kälviäinen R, Ryvlin P, Kugiumtzis D.

Int J Neural Syst. 2015 Aug;25(5):1550018. doi: 10.1142/S0129065715500185. Epub 2015 Mar 18.

PMID:
25986753
43.

Direct Causal Networks for the Study of Transcranial Magnetic Stimulation Effects on Focal Epileptiform Discharges.

Kugiumtzis D, Kimiskidis VK.

Int J Neural Syst. 2015 Aug;25(5):1550006. doi: 10.1142/S0129065715500069. Epub 2015 Jan 19.

PMID:
25761527
44.

Disobedience and driving in patients with epilepsy in Greece.

Zis P, Siatouni A, Kimiskidis VK, Verentzioti A, Kefalonitis G, Triantafyllou N, Gatzonis S.

Epilepsy Behav. 2014 Dec;41:179-82. doi: 10.1016/j.yebeh.2014.09.079. Epub 2014 Oct 26.

PMID:
25461212
45.

The impact of oxaliplatin-based chemotherapy for colorectal cancer on the autonomous nervous system.

Dermitzakis EV, Kimiskidis VK, Eleftheraki A, Lazaridis G, Konstantis A, Basdanis G, Tsiptsios I, Georgiadis G, Fountzilas G.

Eur J Neurol. 2014 Dec;21(12):1471-7. doi: 10.1111/ene.12514. Epub 2014 Jul 17.

PMID:
25041285
46.

Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS).

Lefaucheur JP, André-Obadia N, Antal A, Ayache SS, Baeken C, Benninger DH, Cantello RM, Cincotta M, de Carvalho M, De Ridder D, Devanne H, Di Lazzaro V, Filipović SR, Hummel FC, Jääskeläinen SK, Kimiskidis VK, Koch G, Langguth B, Nyffeler T, Oliviero A, Padberg F, Poulet E, Rossi S, Rossini PM, Rothwell JC, Schönfeldt-Lecuona C, Siebner HR, Slotema CW, Stagg CJ, Valls-Sole J, Ziemann U, Paulus W, Garcia-Larrea L.

Clin Neurophysiol. 2014 Nov;125(11):2150-2206. doi: 10.1016/j.clinph.2014.05.021. Epub 2014 Jun 5. Review.

PMID:
25034472
47.

Correlation networks for identifying changes in brain connectivity during epileptiform discharges and transcranial magnetic stimulation.

Siggiridou E, Kugiumtzis D, Kimiskidis VK.

Sensors (Basel). 2014 Jul 14;14(7):12585-97. doi: 10.3390/s140712585.

48.

Transcranial magnetic stimulation for the diagnosis and treatment of epilepsy.

Kimiskidis VK, Valentin A, Kälviäinen R.

Curr Opin Neurol. 2014 Apr;27(2):236-41. doi: 10.1097/WCO.0000000000000071. Review.

PMID:
24553462
49.

Computational and technological innovations for epilepsy diagnosis and control. Introduction.

Lesser RP, Schachter S, Kimiskidis VK.

Int J Neural Syst. 2014 Mar;24(2):1403001. doi: 10.1142/S0129065714030014. Epub 2014 Jan 22. No abstract available.

PMID:
24475893
50.

Transcranial magnetic stimulation (TMS) modulates epileptiform discharges in patients with frontal lobe epilepsy: a preliminary EEG-TMS study.

Kimiskidis VK, Kugiumtzis D, Papagiannopoulos S, Vlaikidis N.

Int J Neural Syst. 2013 Feb;23(1):1250035. doi: 10.1142/S0129065712500359. Epub 2012 Dec 16.

PMID:
23273131

Supplemental Content

Loading ...
Support Center